Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 701–800 of 1,000
Purcell, E., Owen, S., Prantzalos, E. R., Radomski, A., Carman, N., Lo, T., Zeinali, M., Subramanian, C., Ramnath, N., & Nagrath, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.724389 · Cited by 16
Bryzgunova, O. E., Bondar, A. A., Ruzankin, P., Laktionov, P. P., Tarasenko, A. S., Kurilshikov, A., Epifanov, R., Zaripov, M. M., Kabilov, M. R., & Laktionov, P. P. (2021) · Cancers · doi:10.3390/cancers13246234 · Cited by 16
Kumar, S., Nadda, N., Paul, S. B., Gamanagatti, S. R., Dash, N. R., Vanamail, P., Saraya, A., Shalimar, S., & Nayak, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1024193 · Cited by 16
A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers
Jelovac, D., Beaver, J. A., Sasidharan, B., Wong, H. Y., Toro, P. V., Cimino‐Mathews, A., Argani, P., Stearns, V., Jacobs, L. K., VanDenBerg, D. A., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.10.016 · Cited by 14
Cell-Free DNA as a Novel Marker in Cancer Therapy
Kato, S., & Jankú, F. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.38 · Cited by 17
Han, Y., & Li, J. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0112 · Cited by 15
Fetal Nucleic Acids in Maternal Plasma
Lo, Y. M. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.004 · Cited by 15
Di, W., Chen, Y., Cai, Y., Geng, Q., Tan, Y., Li, C., Wang, Y., Shang, Y., Fang, C., & Cheng, S.-J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1076310 · Cited by 14
Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
Topham, J. T., Renouf, D. J., & Schaeffer, D. F. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231157651 · Cited by 16
Overview of the role of liquid biopsy in cancer management
Assi, T., Khoury, R., Ibrahim, R., Baz, M., Ibrahim, T., & Cesne, A. L. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101702 · Cited by 21
Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid
Bixby, B. A., Vrba, L., Lenka, J., Oshiro, M. M., Watts, G. S., Hughes, T., Erickson, H. L., Chopra, M., Knepler, J. L., Knox, K. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53132-x · Cited by 14
Circulating Cell-Free DNA: The Blood Biopsy in Cancer Management
Yeh, C.-H. (2015) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2015.02.00021 · Cited by 19
Possible application of circulating free tumor DNA in non-small cell lung cancer patients
Karachaliou, N., Sosa, A. E., Molina‐Vila, M. Á., Ruiz, M. C., & Rosell, R. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.09.59 · Cited by 17
The cornerstone of integrating circulating tumor DNA into cancer management
Li, Z., Yi, L., Gao, P., Zhang, R., & Li, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.11.002 · Cited by 14
Cell-Free Circulating Epimarks in Cancer Monitoring
Duforestel, M., Briand, J., Bougras-Cartron, G., Heymann, D., Frenel, J., Vallette, F. M., & Cartron, P. (2020) · Epigenomics · doi:10.2217/epi-2019-0170 · Cited by 16
The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA
Nix, D. A., Hellwig, S., Conley, C. J., Thomas, A., Fuertes, C. L., Hamil, C. L., Bhetariya, P. J., Garrido‐Laguna, I., Marth, G., Bronner, M. P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229063 · Cited by 17
Accurate genotyping of fragmented DNA using a toehold assisted padlock probe
Gao, Y., Qiao, H., Pan, V., Wang, Z., Li, J., Wei, Y., Ke, Y., & Qi, H. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113079 · Cited by 14
Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
Pallante, P., Malapelle, U., Nacchio, M., Sgariglia, R., Galati, D., Capitelli, L., Zanotta, S., Galgani, M., Piemonte, E., Zamparelli, A. S., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11071202 · Cited by 15
Shaban, S. A., Al-Rahim, A. M., & Suleiman, A. A. (2022) · Molecular and Clinical Oncology · doi:10.3892/mco.2022.2519 · Cited by 16
Mazurek, A. M., & Rutkowski, T. W. (2023) · Cancers · doi:10.3390/cancers15041047 · Cited by 18
Hendlisz, A., Golfinopoulos, V., Deleporte, A., Paesmans, M., Mansy, H. E., Garcia, C. A., Peeters, M., Annemans, L., Vandeputte, C., Maetens, M., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-190 · Cited by 15
Bead-based polymerase chain reaction on a microchip
Hilton, J. P., Nguyen, T., Barbu, M., Pei, R., Stojanović, M. N., & Lin, Q. (2012) · Microfluidics and Nanofluidics · doi:10.1007/s10404-012-0993-8 · Cited by 14
Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions
Saliou, A., Bidard, F., Lantz, O. J., Stern, M., Vincent‐Salomon, A., Proudhon, C., & Pierga, J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1121100 · Cited by 16
Tumor‐associated DNA mutation detection in individuals undergoing colonoscopy
Fleshner, P. R., Braunstein, G. D., Ovsepyan, G., Tonozzi, T. R., & Kammesheidt, A. (2017) · Cancer Medicine · doi:10.1002/cam4.1249 · Cited by 15
Khanna, S., Padhan, P., Das, S., Jaiswal, K. S., Tripathy, A., Smita, S., Tripathy, S. K., Raghav, S. K., & Gupta, B. (2018) · ChemistrySelect · doi:10.1002/slct.201802671 · Cited by 14
Zhu, X., Su, S., Fu, M., Peng, Z., Wang, D., Rui, X., Wang, F., Liu, X., Liu, B., Zhu, L., et al. (2019) · The Analyst · doi:10.1039/c9an00637k · Cited by 15
Shen, F., Zailaie, S. A., Chiu, B., Magliocco, A. M., & Sergi, C. M. (2025) · Future Science OA · doi:10.1080/20565623.2025.2527598 · Cited by 19
Udagawa, S., Ooki, A., Shinozaki, E., Fukuda, K., Yamaguchi, K., & Osumi, H. (2023) · Cancers · doi:10.3390/cancers15051473 · Cited by 14
The Correlation between Plasma Circulating Tumor DNA and Radiographic Tumor Burden
Alexander, E. M., Miller, H. A., Egger, M. E., Smith, M. L., Yaddanapudi, K., & Linder, M. W. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.07.001 · Cited by 15
Caën, O., Nizard, P., Garrigou, S., Perez‐Toralla, K., Zonta, E., Laurent‐Puig, P., & Taly, V. (2015) · médecine/sciences · doi:10.1051/medsci/20153102015 · Cited by 16
Schwarzenbach, H. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.980817 · Cited by 15
Enninga, E. A. L., Nevala, W. K., Holtan, S. G., & Markovic, S. N. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00424 · Cited by 14
Lauring, J. D., & Wolff, A. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.4720 · Cited by 13
Rushton, J. G., Ertl, R., Klein, D., Tichy, A., & Nell, B. (2018) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x18762017 · Cited by 15
Roesel, R., Epistolio, S., Molinari, F., Saletti, P., Dosso, S. D., Valli, M., Franzetti-Pellanda, A., Deantonio, L., Biggiogero, M., Spina, P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.900945 · Cited by 14
Shah, U. J., Alsulimani, A., Ahmad, F., Mathkor, D. M., Alsaieedi, A., Harakeh, S., Nasiruddin, M., & Haque, S. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2108994 · Cited by 14
Septin9 DNA methylation as a promising biomarker for cervical cancer
Bu, Q., Luo, X., He, L., Ma, J., He, S., Lei, W., Zhou, W., Deng, H., Yu, L., Zhang, L., et al. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2151356 · Cited by 13
Heteromultivalency enables enhanced detection of nucleic acid mutations
Deal, B. R., Ma, R., Narum, S. M., Ogasawara, H., Duan, Y., Kindt, J. T., & Salaita, K. S. (2023) · Nature Chemistry · doi:10.1038/s41557-023-01345-4 · Cited by 13
An analysis of quantitative PCR reliability through replicates using the Ct method
Stowers, C. C., Haselton, F. R., & Boczko, E. M. (2010) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2010.35064 · Cited by 14
Chakravadhanula, M., Tembe, W., Legendre, C., Carpentieri, D. F., Liang, W. S., Bussey, K. J., Carpten, J. D., Berens, M. E., & Bhardwaj, R. D. (2013) · Journal of Child Neurology · doi:10.1177/0883073813503904 · Cited by 13
Molecular Screening Testing for Colorectal Cancer
Levin, B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0578 · Cited by 12
Circulating DNA-Important Biomarker of Cancer
Xie, D. J. S. (2012) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.s2-009 · Cited by 14
Trombetta, D., Sparaneo, A., Fabrizio, F. P., & Muscarella, L. A. (2016) · Lung Cancer Management · doi:10.2217/lmt-2016-0006 · Cited by 16
de Bruin, E. C., Whiteley, J. L., Corcoran, C., Kirk, P. M., Fox, J. C., Armisen, J., Lindemann, J. P. O., Schiavon, G., Ambrose, H. J., & Kohlmann, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175779 · Cited by 13
Sugimachi, K., Sakimura, S., Kuramitsu, S., Hirata, H., Niida, A., Iguchi, T., Eguchi, H., Masuda, T., Morita, M., Toh, Y., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0208-5 · Cited by 14
Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know
Calandri, M., Siravegna, G., Yevich, S. M., Stranieri, G., Gazzera, C., Kopetz, S., Fonio, P., Gupta, S. K., Bardelli, A., Veltri, A., et al. (2020) · European Radiology · doi:10.1007/s00330-020-06700-4 · Cited by 13
Thakral, D., Das, N., Basnal, A., & Gupta, R. (2020) · PubMed · Cited by 21
Mutation enrichment in human DNA samples via UV-mediated cross-linking
Leong, K. W., Yu, F., & Makrigiorgos, G. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1222 · Cited by 13
Diagnostic and Therapeutic Response Markers
Lennon, A. M., & Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_28 · Cited by 13
Alrumaihi, F. (2025) · Diagnostics · doi:10.3390/diagnostics15131655 · Cited by 20
Kampel, L., Feldstein, S., Tsuriel, S., Hannes, V., Neiderman, N. N. C., Horowitz, G., Warshavsky, A., Leider–Trejo, L., Hershkovitz, D., & Muhanna, N. (2023) · Biomolecules · doi:10.3390/biom13091418 · Cited by 15
The role of circulating tumor DNA in melanomas of the uveal tract
Zameer, M. Z., Jou, E., & Middleton, M. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1509968 · Cited by 13
Science in Focus: Circulating Tumour DNA as a Liquid Biopsy
O’Leary, B., & Turner, N. C. (2016) · Clinical Oncology · doi:10.1016/j.clon.2016.08.007 · Cited by 12
Krämer, T. J., Hübener, P., Pöttker, B., Gölz, C., Neulen, A., Pantel, T., Goetz, H., Ritter, K., Schäfer, M. K. E., & Thal, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-09326-2 · Cited by 14
Deng, L., Qi, Z., Zou, B., Wu, H., Huang, H., Kajiyama, T., Kambara, H., & Zhou, G. (2012) · Analytical Chemistry · doi:10.1021/ac3008016 · Cited by 12
Palliative Treatment of Metastatic Colorectal Cancer: What is the Optimal Approach?
Strickler, J. H., & Hurwitz, H. I. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0363-z · Cited by 13
Park, K. U., Lee, H. E., Nam, S. K., Nam, K. H., Park, D. J., Kim, H., Kim, W. H., & Lee, H. S. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0988 · Cited by 12
Liu, X., & Chu, K. (2015) · Neoplasma · doi:10.4149/neo_2016_002 · Cited by 12
Assessing the Diagnostic Value of Plasma-Free DNA in Prostate Cancer Screening
Seyedolmohadessin, S. M., Akbari, M. T., Nourmohammadi, Z., Basiri, A., & Pourmand, G. (2018) · Iranian Biomedical Journal · doi:10.29252/ibj.22.5.331 · Cited by 14
Sanromán-Iglesias, M., Lawrie, C. H., Liz‐Marzán, L. M., & Grzelczak, M. (2018) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b00984 · Cited by 12
Malbec, R., Cacheux, J., Cordelier, P., Leïchlé, T., Joseph, P., & Bancaud, A. (2018) · Micro and Nano Engineering · doi:10.1016/j.mne.2018.10.003 · Cited by 13
Potential of Using Cell‐Free DNA and miRNA in Breast Milk to Screen Early Breast Cancer
Song, Q., Zhang, Y., Liu, H., & Du, Y. (2020) · BioMed Research International · doi:10.1155/2020/8126176 · Cited by 13
Gassa, A., Fassunke, J., Schüten, S., Kuhlmann, L., Scherer, M., Qien, J., Zhao, Y., Michel, M., Loeser, H., Wolf, J., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.10.019 · Cited by 12
Genomic insights in gynecologic cancer
Roddy, E., & Chapman, J. (2016) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2016.11.001 · Cited by 12
Barros, B. D. D. F., Kupper, B. E. C., Aguiar, S., de Mello, C. A. L., Begnami, M. D., Chojniak, R., SOUZA, S. J. D., Torrezan, G. T., & Carraro, D. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00306 · Cited by 13
Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma
Syeda, M. M., Wiggins, J. M., Corless, B. C., Spittle, C., Karlin-Neumann, G. A., & Polsky, D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9773-2_7 · Cited by 12
A New Paradigm of the Origins of Circulating DNA in Patients with Cancer
Thierry, A. R., & Pisareva, E. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0824 · Cited by 12
Lu, J., Feng, Y., Guo, K., Sun, L., Ruan, S., & Zhang, K. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05550-z · Cited by 11
Updates on Liquid Biopsy and ctDNA in Transplant Oncology
Loszko, A. F., Byrne, M., Jiménez-Soto, C., Tomiyama, K., Bekki, Y., & Hernandez‐Alejandro, R. (2025) · Cancers · doi:10.3390/cancers17121930 · Cited by 13
Rapisuwon, S., BUSAM, K. J., Parks, K., Chapman, P. B., Lee, E., & Atkins, M. B. (2016) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000000660 · Cited by 12
Liquid biopsy for the detection and management of surgically resectable tumors
Blanco, B. A., & Wolfgang, C. L. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01788-9 · Cited by 11
Xie, H., & Kim, R. D. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09002-7 · Cited by 11
Jiang, X., Li, W., Yang, J., Wang, S., Cao, D., Yu, M. Y., Shen, K., Bai, J., & Gao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.582546 · Cited by 11
Merk, C., Martling, A., Lindberg, J., Benhaïm, L., Taïeb, J., & Lind, P. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2033831 · Cited by 14
Ahmad, E., Ali, A., Nimisha, Sharma, A. K., Apurva, A., Kumar, A., Dar, G. M., Sattar, R. S. A., Verma, R., Mahajan, B., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.029 · Cited by 11
Circulating DNA and Next-Generation Sequencing
Cooke, S. L., & Campbell, P. J. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_12 · Cited by 11
Molecular profiling in the age of cancer genomics
Lin, J., & Li, M. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.3.263 · Cited by 12
Self-citationColorectal cancer screening: are stool and blood based tests good enough?
Wu, C., & Sung, J. J. �. (2013) · PubMed · doi:10.3978/j.issn.2304-3865.2012.11.07 · Cited by 13
A Simple and Fast Assay Based on Carboxyfluorescein-Loaded Liposome for Quantitative DNA Detection
Sforzi, J., Ferrauto, G., Aime, S., & Crich, S. G. (2020) · ACS Omega · doi:10.1021/acsomega.9b01457 · Cited by 11
Sundquist, K., Sundquist, J., Hedelius, A., & Memon, A. A. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23261 · Cited by 11
Highly sensitive mutation detection based on digital amplification coupled with hydrogel bead-array
Huang, H., Qi, Z., Deng, L., Zhou, G., Kajiyama, T., & Kambara, H. (2009) · Chemical Communications · doi:10.1039/b902196e · Cited by 11
Chen, H., Zhang, J., Chen, H., Su, B., & Lu, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-6754 · Cited by 11
Xu, W., Peng, J., Guo, C., Chai, Y., Hai‐Meng, Z. H. O. U., Wang, J., & Li, X. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.133231 · Cited by 10
Liao, Y., Ma, Z., Zhang, Y., Li, D., Lv, D., Chen, Z., Li, P., AI-Dherasi, A. M., Zheng, F., Tian, J., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2458 · Cited by 10
The History and Future of Basic and Translational Cell-Free DNA Research at a Glance
Gahan, P. B., Schwarzenbach, H., & Anker, P. (2022) · Diagnostics · doi:10.3390/diagnostics12051192 · Cited by 10
Advances in liquid biopsy in neuroblastoma
Zhuo, Z., Lin, L., Miao, L., Li, M., & He, J. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.08.005 · Cited by 12
Self-citationRecent Developments in Blood Biomarkers in Neuro-oncology
Foster, J., Koptyra, M., & Bagley, S. J. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01321-y · Cited by 12
Nicolini, C., Ens, C. M. B., Cerutti, T., Roehe, A. V., Agnes, G., Damin, A. P. S., & Alexandre, C. O. P. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0120 · Cited by 10
Circulating tumor DNA and their added value in molecular oncology
Leers, M. P. G. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0436 · Cited by 13
Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
Lenaerts, L., Tuveri, S., Jatsenko, T., Amant, F. C., & Vermeesch, J. R. (2019) · Acta Clinica Belgica · doi:10.1080/17843286.2019.1671653 · Cited by 11
Lampis, A., Ghidini, M., Ratti, M., Mirchev, M. B., Okuducu, A. F., Valeri, N., & Hahne, J. C. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2030022 · Cited by 11
Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide
Gurioli, G., Conteduca, V., Lolli, C., Schepisi, G., Gargiulo, S., Altavilla, A., Casadei, C., Scarpi, E., & Giorgi, U. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.567809 · Cited by 10
Sun, Y., An, K., & Yang, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80730 · Cited by 10
Manueldas, S., Benterud, T., Rueegg, C. S., Garberg, H. T., Huun, M. U., Pankratov, L., Atneosen‐Åsegg, M., Solberg, R., Escobar, J., Saugstad, O. D., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206601 · Cited by 10
Atkins, A., Gupta, P., Zhang, B. M., Tsai, W., Lucas, J., Javey, M., Vora, A., & Mei, R. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00406-0 · Cited by 9
The role of exosomal microRNAs; focus on clinical applications in breast cancer
Sueta, A., Yamamoto, Y., & Iwase, H. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.17 · Cited by 12
Emaus, M. N., & Anderson, J. L. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03216-8 · Cited by 10
Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA
Cutts, A., Venn, O., Dilthey, A., Gupta, A., Vavoulis, D. V., Dreau, H. M.-P., Middleton, M. R., McVean, G., Taylor, J. C., & Schuh, A. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0030-7 · Cited by 9
Zhang, Z., Ji, Q., Zhang, Z., Lyu, B., Li, P., Zhang, L.-Y., Chen, K., Fang, M., & Song, J. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.02.008 · Cited by 9
RetractedCirculating tumor DNA in colorectal cancer: biology, methods and applications
Chen, H., An, Y., Wang, C., & Zhou, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02220-z · Cited by 15
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.